硼中子捕获疗法市场（按中子源、硼化合物、应用和最终用户）－2025-2030 年全球预测

硼中子捕获疗法市场预计到 2024 年将达到 4.1715 亿美元，到 2025 年将达到 5.1747 亿美元，到 2030 年将达到 15.897 亿美元，复合年增长率为 24.97%。

主要市场统计数据
基准年2024年	4.1715亿美元
预计2025年	5.1747亿美元
预测年份 2030	15.897亿美元
复合年增长率（%）	24.97%

硼中子捕获疗法透过精确瞄准恶性细胞同时保护健康组织，改变了癌症治疗方法

硼中子捕获疗法代表了肿瘤学的模式转移，它提供了一种利用硼-10原子与低能中子的核反应，仅在恶性细胞内诱发致命损伤的方法。此机制依赖肿瘤对含硼化合物的选择性吸收，并随后以中子束进行辐照。吸收中子后，硼-10发生核分裂，产生高能量α粒子和锂核。因此，恶性肿瘤周围的健康组织基本上不受损害，从而减少了通常与外部照射相关的不利事件。

新兴先进中子源技术与简化监管途径塑造硼中子捕获疗法的未来

近年来，紧凑型加速器中子源的出现改变了硼中子捕获疗法的技术格局，这些中子源是对传统核子反应炉设施的补充。包括迴旋加速器和线性加速器在内的粒子加速器系统如今能够提供局部中子束，减少对基础设施的需求，使治疗中心能够在医院院区内部署硼中子捕获疗法 (BNCT) 能力。这些技术创新规避了与核子反应炉授权和放射性物质运输相关的后勤挑战，同时提供了可自订的束流频谱，从而提高了治疗精度。因此，质子和氘核驱动的加速器平台持续受到关注，将这种治疗方法从集中式研究核子反应炉转移到更容易获得的临床环境中。

评估美国关税政策对硼中子捕获疗法供应链动态和成本结构的整体影响

美国政府近期实施的关税措施对硼中子捕获疗法所需的关键进口原料（包括高纯度硼化合物和专用中子源组件）征收了高关税。这个政策环境为硼化卟啉、硼苯丙胺酸和硼辛酸钠製造商以及核子反应炉和加速器组件製造商带来了成本压力。这些措施可能导致临床机构和研究机构的采购支出增加，对财务规划带来挑战，并减缓设备升级的步伐。

确定硼化合物变体在中子源模式中的临床应用以及根据最终用户概况确定的独特市场途径

对中子源模式的分析表明，传统核子反应炉仍在支持许多早期的硼中子俘获疗法临床项目，提供性能优异的高通量束流。然而，粒子加速器系统因其紧凑的体积和较低的监管负担，正在迅速发展壮大。在加速器类别中，迴旋加速器因其成熟可靠而备受青睐，而线性加速器提供可调的频谱，并可与现有的放射肿瘤学基础设施整合。这种技术差异为计划长期扩张的治疗中心提供了两种截然不同的路径。

分析硼中子捕获疗法的区域发展势头，重点介绍美洲、欧洲、中东、非洲和亚太地区的驱动因素和合作生态系统

美国透过专门的研究中心和试验治疗设施，率先在临床上应用硼中子捕获疗法。联邦和州政府的研究津贴支持了转化项目，以改善剂量测定技术和硼输送系统。加拿大拥有强大的核子反应炉传统，正在为基于核子反应炉的研究做出贡献，并促进学术医疗中心和工业赞助商之间的伙伴关係。在整个拉丁美洲，一些合作倡议正在涌现，旨在评估硼中子捕获疗法在当地常见肿瘤适应症中的应用，儘管基础设施限制仍然是其广泛应用的障碍。

检验领先的生物技术、製药和研究机构在推进硼中子捕获疗法方面的策略创新和合作努力

一群先驱企业正透过对技术开发和临床专案的策略性投资，塑造硼中子捕获疗法的发展轨迹。成熟的重工业领导者正利用其在迴旋加速器和线性加速器工程方面的专业知识，为医疗环境量身打造中子束平台。同时，专业的生物技术公司正专注于下一代硼载体的研发，优化分子结构以增强肿瘤标靶化和滞留性，同时最大限度地降低全身辐射暴露。硬体和放射性药物创新的融合，支撑着一个不断发展且功能互补的生态系统。

实施有针对性的策略蓝图，促进跨部门伙伴关係，扩大基础建设，加强硼中子捕获疗法的监管参与

致力于掌握硼中子捕获疗法发展机会的行业领导者应优先考虑建立一个跨部门联盟，汇聚加速器製造商、放射性药物开发商和临床终端用户的专业知识。透过在结构化的协作框架内召集相关人员，各组织可以协调中子源技术规范，协调硼药物供应链，并使临床试验设计符合监管要求。此类伙伴关係将促进规模经济，加速通讯协定标准化，并降低设施建设成本。

结合定性专家访谈、定量资料整理和严格检验通讯协定的强大多维研究框架的详细信息

本研究采用多层次研究框架，旨在捕捉硼中子捕获疗法的策略性洞察与操作细节。主要研究包括对顶尖肿瘤学家、医学物理学家、放射药理学家和策略高管的深入访谈，提供有关技术进步、临床挑战和市场动态的第一手观点。这些访谈揭示了治疗计划的复杂性、设施要求和患者体验等关键因素。为了补充这些洞察，次要研究包括全面检索同侪审查的科学文献、监管备案文件、产业白皮书和专利申请，以全面了解技术创新轨迹和智慧财产权格局。

整合核心知识，突显策略挑战，加速临床整合，推动硼中子捕获疗法持续创新

这项分析强调，硼中子捕获疗法已达到曲折点，其特点是先进的运载剂、微型加速器平台的兴起以及支持性监管框架。核子反应炉和加速器治疗方法的区别，加上硼化卟啉、苯丙胺酸类似物和硼酸酯化合物的进展，预示着治疗前景日趋成熟。临床重点关注胶质母细胞瘤、头颈癌和黑色素瘤等高难度适应症，证明了该方法的多功能性和针对性疗效。治疗中心、医院和研究机构之间的合作网络促进了知识交流和通讯协定优化。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 扩大紧凑型加速器驱动中子源的开发，用于临床BNCT应用
• 製药公司与研究机构就下一代硼载体进行策略合作
• 美国和欧盟等主要市场的BNCT设备监管途径和快速核准流程
• 整合即时成像和剂量测定技术提高硼中子捕获治疗的准确性
• 临床试验结果证明，BNCT 治疗头颈癌具有成本效益，且可提高存活率
• BNCT治疗中针对肿瘤异质性的个人化硼化合物製剂的出现
• 增加亚太地区和北美地区BNCT基础设施和治疗中心的投资
• 制定BNCT程序的标准化报销框架和保险覆盖政策
• 放射生物学建模和治疗计划软体的进步，以优化BNCT治疗窗口
• 引入机器人辅助患者定位系统，减少BNCT治疗中的设定错误

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

8. 硼中子捕获疗法市场（依中子源）

• 核子反应炉
• 粒子加速器
  • 迴旋加速器
  • 直线加速器

9. 硼中子捕获疗法市场-硼化合物

• 硼化卟啉
• 硼苯丙胺酸
• 硼酸钾钠

第 10 章 硼中子捕获治疗市场（依应用）

• 脑肿瘤
  • 神经胶母细胞瘤
  • 脑膜瘤
• 乳癌
• 头颈癌
• 黑色素瘤

第 11 章 硼中子捕获疗法市场（依最终用户）

• 癌症治疗中心
• 医院
• 科学研究机构和大学

12.美国硼中子捕获治疗市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

13. 欧洲、中东和非洲硼中子捕获疗法市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

14. 亚太地区硼中子捕获疗法市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十五章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Aviko Radiopharmaceuticals, LLC
  • BEVATECH GmbH
  • Cosylab
  • International Particle Therapy Inc.
  • Neuboron Medtech Ltd.
  • Neutron Therapeutics, LLC
  • RaySearch Laboratories
  • Stellapharm JV Co., Ltd.
  • Sumitomo Heavy Industries, Ltd.
  • TAE Life Sciences

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

The Boron Neutron Capture Therapy Market was valued at USD 417.15 million in 2024 and is projected to grow to USD 517.47 million in 2025, with a CAGR of 24.97%, reaching USD 1,589.70 million by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 417.15 million
Estimated Year [2025]	USD 517.47 million
Forecast Year [2030]	USD 1,589.70 million
CAGR (%)	24.97%

Transforming Cancer Treatment by Harnessing Boron Neutron Capture Therapy to Precisely Target Malignant Cells While Preserving Healthy Tissue

Boron neutron capture therapy represents a paradigm shift in oncology, offering an approach that leverages the nuclear reaction between boron-10 atoms and low-energy neutrons to induce lethal damage exclusively within malignant cells. This mechanism relies on the selective uptake of a boron-containing compound by the tumor, followed by irradiation with a neutron beam. Upon neutron capture, boron-10 undergoes fission to produce high-energy alpha particles and lithium nuclei, each traveling only a few micrometers and thereby confining cytotoxic effects to the tumor margin. Consequently, healthy tissue surrounding the malignancy remains largely unharmed, reducing adverse events commonly associated with external beam radiation.

Over the past decade, advancements in radiopharmaceutical design and neutron source technology have revitalized interest in this treatment modality. State-of-the-art boron carriers demonstrate improved tumor selectivity and blood-brain barrier permeability, while compact accelerator-based neutron sources have emerged to complement traditional reactor facilities. With early clinical trials reporting encouraging outcomes in refractory head and neck cancers and aggressive brain tumors, boron neutron capture therapy is advancing from a niche investigational therapy toward broader clinical applicability. Looking ahead, the fusion of insights from radiobiology, material science, and medical physics will continue to refine treatment protocols, bolster safety profiles, and expand the therapeutic window of this highly targeted cancer intervention.

Since its conceptualization in the mid-20th century, boron neutron capture therapy encountered logistical and technical hurdles, including limited neutron accessibility and suboptimal boron delivery vectors. Nevertheless, multidisciplinary collaborations among physicists, chemists, and clinicians have surmounted many of these barriers. Notably, refinements in neutron moderation and beam delivery systems now facilitate more precise treatment planning and dosimetry. Moreover, ongoing partnerships between academic institutions and industry sponsors are fueling pioneering studies that integrate immunomodulatory strategies with neutron capture therapy, potentially synergizing innate immune responses with localized cytotoxicity. As these collaborative endeavors mature, they illuminate a path toward personalized radiation oncology where treatment regimens are tailored to individual tumor biology and patient physiology. Collectively, the integration of robust preclinical models, enhanced imaging modalities, and novel boron payloads is shaping a future in which boron neutron capture therapy becomes a cornerstone of multidisciplinary cancer management.

Emergence of Advanced Neutron Source Technologies and Streamlined Regulatory Pathways Shaping the Future of Boron Neutron Capture Therapy

In recent years, the technological landscape of boron neutron capture therapy has been transformed by the advent of compact accelerator-based neutron sources that complement conventional nuclear reactor facilities. Particle accelerator systems, including cyclotrons and linear accelerators, now provide localized neutron beams with reduced infrastructural demands, enabling treatment centers to deploy BNCT capabilities within hospital campuses. These innovations circumvent the logistical challenges associated with reactor licensing and transportation of radioactive materials, while also offering customizable beam spectra that improve treatment precision. As a result, proton-driven and deuteron-driven accelerator platforms continue to gain traction, shifting the modality from centralized research reactors toward more accessible clinical environments.

Concurrently, regulatory authorities across key markets have introduced frameworks to expedite the approval of novel radiopharmaceuticals and associated delivery systems. Adaptive regulatory pathways now facilitate early patient access under conditional marketing authorizations, contingent upon post-market evidence generation. This shift reflects a growing recognition of the unmet need in treating radioresistant and recurrent tumors, and it has encouraged manufacturers to engage in early dialogue with health agencies. Consequently, trial designs emphasize safety and efficacy endpoints tailored to the unique mechanistic profile of BNCT, fostering a more collaborative regulatory environment.

Furthermore, integration of digital treatment planning tools and artificial intelligence-driven imaging algorithms has enhanced dosimetric accuracy and patient stratification. Through sophisticated modeling of neutron flux distributions and boron uptake kinetics, clinicians can optimize treatment plans in silico prior to irradiation. Taken together, these transformative shifts in both technology and regulation underpin a next-generation ecosystem for boron neutron capture therapy, setting the stage for broader clinical adoption and improved patient outcomes.

Assessing the Aggregated Consequences of United States Tariff Policies on Supply Chain Dynamics and Cost Structures in Boron Neutron Capture Therapy

Recent tariff measures enacted by the United States government have imposed elevated duties on key imported inputs essential to boron neutron capture therapy, including high-purity boron compounds and specialized neutron source components. This policy environment has introduced cost pressures for producers of boronated porphyrins, boronophenylalanine, and sodium borocaptate, as well as for manufacturers of reactor and accelerator assemblies. Such duties have translated into higher procurement expenditures for clinical sites and research institutions, challenging financial planning and potentially slowing the pace of equipment upgrades.

In response, industry stakeholders are exploring strategies to mitigate tariff-related impacts by diversifying supply chains and enhancing domestic production capabilities. Collaborative agreements between biotechnology firms and chemical synthesis laboratories aim to establish onshore manufacturing lines for boron agents. Similarly, equipment suppliers are evaluating joint ventures to localize critical subassembly production, thereby reducing exposure to import duties. At the same time, research consortia are investigating alternative boron carrier molecules that may circumvent current tariff classifications while maintaining or improving therapeutic performance.

Despite these headwinds, sustained investment incentives and federal research grants continue to underpin expansion of BNCT infrastructure. Furthermore, dialogue with policy makers has underscored the importance of stable trade policies for maintaining the United States' leadership in innovative cancer therapies. As tariff frameworks evolve beyond 2025, stakeholders will need to balance cost containment with the imperative to drive continued technological advancement, ensuring that boron neutron capture therapy remains both economically and clinically viable.

Unearthing Distinct Market Pathways through Neutron Source Modalities Boron Compound Variants Clinical Applications and End-User Profiles

Analysis of neutron source modalities reveals that traditional nuclear reactors continue to underpin many early clinical programs for boron neutron capture therapy, providing high-flux beams that are well characterized. However, particle accelerator systems are rapidly gaining momentum due to their compact footprints and reduced regulatory burdens. Within the accelerator category, cyclotrons have become favored for their maturity and reliability, while linear accelerators offer adjustable energy spectra and potential integration with existing radiation oncology infrastructure. This technological divergence delineates two distinct pathways for treatment centers planning long-term expansion.

Turning to boron compound variants, boronated porphyrins represent a pioneering class of agents owing to their strong tumor affinity and established safety profiles. Boronophenylalanine has emerged as a workhorse in neurooncology applications because of its capacity to traverse the blood-brain barrier and accumulate in glial malignancies, whereas sodium borocaptate offers versatility in broader cancer types due to favorable pharmacokinetics and reduced off-target toxicity. The comparative performance of these compounds continues to inform formulation strategies and dosing protocols.

Clinical application segmentation highlights that brain tumors, most notably glioblastoma and meningioma, remain the primary focus of BNCT research owing to limited treatment alternatives and high unmet need. Concurrently, head and neck cancers have seen encouraging response rates in recurrent cases, and exploratory studies in breast cancer and melanoma are underway to assess the therapy's broader oncological relevance. These developments reflect a strategic prioritization of indications with both significant clinical challenges and established pathways for regulatory review.

End-user segmentation encompasses cancer treatment centers that invest in specialized BNCT suites, general hospitals integrating accelerator-based units alongside conventional radiation therapy, and research institutes or universities that drive early-phase trials and basic science innovations. The collaborative interplay among these stakeholders fosters a continuum from discovery to clinical deployment, shaping distinct adoption curves and investment imperatives.

Dissecting Regional Momentum in Boron Neutron Capture Therapy Emphasizing Growth Drivers and Collaborative Ecosystems across Americas EMEA and Asia-Pacific

In the Americas, the United States has spearheaded clinical implementation of boron neutron capture therapy through dedicated research centers and pilot treatment sites. Federal and state research grants have supported translational programs that refine dosimetry techniques and boron delivery systems. Canada, with its robust reactor heritage, contributes to reactor-based research and fosters partnerships between academic medical centers and industry sponsors. Across Latin America, collaborative initiatives are emerging to evaluate BNCT in locally prevalent tumor indications, although infrastructure constraints remain a barrier to widespread adoption.

Within Europe, Middle East & Africa, European Union member states such as Germany, the United Kingdom, and Italy continue to drive reactor-based and accelerator-based studies. Robust research consortia integrate national laboratories, universities, and biotech firms to accelerate clinical trial enrollment and regulatory submissions. Meanwhile, countries in the Middle East have begun to explore BNCT through strategic alliances with established European centers, prioritizing technology transfer and capacity building. In Africa, nascent research programs are laying groundwork for future engagement, with academic institutions focusing on feasibility studies and epidemiological assessments of cancer types amenable to neutron capture therapy.

The Asia-Pacific landscape is characterized by both mature and rapidly expanding activity. Japan remains at the forefront, having secured regulatory clearances and established commercial BNCT suites, while China pursues ambitious investment in accelerator infrastructure and boron carrier R&D. South Korea has leveraged its advanced medical device ecosystem to pilot novel accelerator designs, and Australia is exploring cross-institutional collaborations to integrate BNCT into national cancer strategies. Collectively, the Asia-Pacific region exemplifies a dynamic network of government support, private investment, and academic leadership that is propelling boron neutron capture therapy toward broader accessibility.

Examining Strategic Innovations and Collaborative Endeavors among Leading Biotech Pharmaceutical and Research Organizations Advancing Boron Neutron Capture Therapy

A cohort of pioneering organizations is shaping the trajectory of boron neutron capture therapy through strategic investments in technology development and clinical programs. Established heavy industry leaders are leveraging their expertise in cyclotron and linear accelerator engineering to tailor neutron beam platforms for medical settings. In parallel, specialty biotech firms are focusing on next-generation boron carriers, optimizing molecular structures to enhance tumor targeting and retention while minimizing systemic exposure. This convergence of hardware and radiopharmaceutical innovation underpins an evolving ecosystem replete with complementary capabilities.

Several pharmaceutical developers have recently engaged in collaborative alliances to co-develop boron delivery agents and companion diagnostics. These partnerships facilitate access to advanced formulation technologies and clinical trial networks while sharing the risks inherent in pioneering treatment paradigms. At the same time, research universities and national laboratories contribute fundamental insights into boron pharmacokinetics and neutron beam interaction with complex tissue matrices. By participating in multi-center studies, these institutions are validating novel treatment protocols and generating evidence required for regulatory approval.

Market entrants specializing in accelerator solutions have also forged strategic relationships with leading oncology centers, enabling early-stage clinical demonstrations of their platforms. Such alliances not only accelerate patient recruitment but also provide critical feedback loops to optimize system performance and treatment workflows. Additionally, pharmaceutical companies are exploring licensing agreements for boron agents that can be adapted to multiple accelerator modalities, thereby streamlining commercialization pathways across diverse clinical environments. Through this dynamic interplay of collaboration, investment, and knowledge exchange, organizations across the biotech, pharmaceutical, and research spectrums are collectively advancing the frontiers of boron neutron capture therapy.

Implementing Targeted Strategic Roadmaps to Foster Cross-Sector Partnerships Scale Infrastructure and Enhance Regulatory Engagement for Boron Neutron Capture Therapy

Industry leaders seeking to capitalize on the promise of boron neutron capture therapy should prioritize the establishment of cross-sector consortia that integrate expertise from accelerator manufacturers, radiopharmaceutical developers, and clinical end-users. By convening stakeholders in structured collaboration frameworks, organizations can harmonize technical specifications for neutron sources, coordinate boron agent supply chains, and align clinical trial designs to regulatory expectations. Such partnerships will foster economies of scale, accelerate protocol standardization, and mitigate the costs of facility build-out.

Simultaneously, scaling infrastructure through modular accelerator installations can lower entry barriers for treatment centers. Modular cyclotron or linear accelerator units deliver the flexibility to tailor beam energy profiles for specific indications, while enabling phased capacity expansion. Investing in standardized quality management systems and workforce training programs will ensure that medical physicists, dosimetrists, and technologists possess the competencies required for safe and effective deployment of BNCT. Workforce development initiatives should incorporate immersive simulation exercises and certification pathways to cultivate a pipeline of skilled practitioners.

Engaging early and proactively with regulatory agencies is also critical. Developers should seek scientific advice to refine trial endpoints, optimize dosing regimens, and design post-market evidence collection strategies. Generating robust real-world data through patient registries will support health authority submissions and facilitate payer negotiations, thereby enhancing reimbursement prospects. To support patient access, organizations are encouraged to collaborate with advocacy groups to raise awareness of BNCT's clinical benefits and to pilot value-based care models.

By implementing these strategic roadmaps, industry players can synchronize technological innovation with clinical and regulatory imperatives. In doing so, they will lay the foundation for sustainable growth, ensuring that boron neutron capture therapy matures into a widely accessible and durable component of contemporary oncology practice.

Detailing a Robust Multi-Dimensional Research Framework Combining Qualitative Expert Interviews Quantitative Data Collation and Rigorous Validation Protocols

This study leveraged a multi-dimensional research framework designed to capture both strategic insights and operational nuances of boron neutron capture therapy. Primary research included in-depth interviews with leading oncologists, medical physicists, radiopharmacologists, and strategic executives, providing firsthand perspectives on technological advancements, clinical challenges, and market dynamics. These dialogues illuminated critical factors such as treatment planning complexities, facility requirements, and patient experience considerations. Complementing these insights, secondary research encompassed a comprehensive review of peer-reviewed scientific literature, regulatory submissions, industry white papers, and patent filings, enabling a holistic understanding of innovation trajectories and intellectual property landscapes.

Quantitative data collation involved the systematic aggregation of clinical trial registries, published outcome data, and manufacturing capacity reports. Where appropriate, anonymized data points from institutional registries were synthesized to validate emerging trends in treatment utilization and compound performance. To ensure the highest standards of accuracy, all findings underwent rigorous triangulation, cross-referencing multiple information sources to reconcile discrepancies and confirm reliability.

Validation protocols featured iterative workshops with an expert advisory panel comprising practitioners, researchers, and regulatory affairs professionals. This collaborative forum reviewed draft analyses, offering critical feedback on methodological assumptions, data interpretations, and strategic recommendations. Through a transparent process of review and refinement, the research outcomes were calibrated to align with real-world practice and stakeholder expectations. Collectively, this rigorous methodology underpins the credibility and relevance of the strategic insights presented herein.

Synthesizing Core Findings and Emphasizing Strategic Imperatives to Accelerate Clinical Integration and Drive Sustained Innovation in Boron Neutron Capture Therapy

The analysis underscores that boron neutron capture therapy has reached an inflection point, characterized by refined delivery agents, the rise of compact accelerator platforms, and supportive regulatory frameworks. The distinction between reactor-based and accelerator-based modalities, coupled with advancements in boronated porphyrins, phenylalanine analogs, and borocaptate compounds, illustrates a maturing therapeutic landscape. Clinical focus on challenging indications such as glioblastoma, head and neck cancers, and melanoma demonstrates both the versatility and targeted efficacy of this approach, while collaborative networks among treatment centers, hospitals, and research institutions are driving knowledge exchange and protocol optimization.

Moving forward, industry participants must prioritize supply chain diversification and domestic manufacturing capacities to mitigate tariff-related uncertainties. Scaling modular neutron source installations and standardizing workforce training will reduce operational barriers and support rapid deployment. Proactive engagement with regulatory bodies and the generation of real-world evidence through patient registries will streamline approval pathways and reimbursement discussions. Cross-sector partnerships that integrate technical, pharmaceutical, and clinical expertise will catalyze innovation and ensure alignment with healthcare stakeholder requirements.

By embracing these strategic imperatives, organizations can solidify boron neutron capture therapy as a core component of precision oncology. Continued investment in research, infrastructure, and collaborative frameworks will be instrumental in translating this promising modality into widespread clinical practice, ultimately improving outcomes for patients with limited treatment alternatives.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Expansion of compact accelerator-driven neutron source development for clinical BNCT applications
• 5.2. Strategic collaborations between pharmaceutical companies and research institutes for next-generation boron carriers
• 5.3. Regulatory pathways and expedited approval processes for BNCT devices in major markets such as the US and EU
• 5.4. Integration of real-time imaging and dosimetry techniques to enhance precision in boron neutron capture therapy
• 5.5. Clinical trial results demonstrating cost-effectiveness and survival benefits of BNCT in head and neck cancer
• 5.6. Emergence of personalized boron compound formulations targeting tumor heterogeneity in BNCT treatments
• 5.7. Increasing investments in BNCT infrastructure and treatment centers across Asia Pacific and North America
• 5.8. Development of standardized reimbursement frameworks and insurance coverage policies for BNCT procedures
• 5.9. Advances in radiobiological modeling and treatment planning software optimizing BNCT therapeutic windows
• 5.10. Implementation of robot-assisted patient positioning systems to reduce setup errors in BNCT therapies

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Boron Neutron Capture Therapy Market, by Neutron Sources

• 8.1. Introduction
• 8.2. Nuclear Reactors
• 8.3. Particle Accelerators
  • 8.3.1. Cyclotrons
  • 8.3.2. Linacs

9. Boron Neutron Capture Therapy Market, by Boron Compound

• 9.1. Introduction
• 9.2. Boronated Porphyrins
• 9.3. Boronophenylalanine
• 9.4. Sodium Borocaptate

10. Boron Neutron Capture Therapy Market, by Application

• 10.1. Introduction
• 10.2. Brain Tumors
  • 10.2.1. Glioblastoma
  • 10.2.2. Meningioma
• 10.3. Breast Cancer
• 10.4. Head & Neck Cancer
• 10.5. Melanoma

11. Boron Neutron Capture Therapy Market, by End-User

• 11.1. Introduction
• 11.2. Cancer Treatment Centers
• 11.3. Hospitals
• 11.4. Research Institutes & Universities

12. Americas Boron Neutron Capture Therapy Market

• 12.1. Introduction
• 12.2. United States
• 12.3. Canada
• 12.4. Mexico
• 12.5. Brazil
• 12.6. Argentina

13. Europe, Middle East & Africa Boron Neutron Capture Therapy Market

• 13.1. Introduction
• 13.2. United Kingdom
• 13.3. Germany
• 13.4. France
• 13.5. Russia
• 13.6. Italy
• 13.7. Spain
• 13.8. United Arab Emirates
• 13.9. Saudi Arabia
• 13.10. South Africa
• 13.11. Denmark
• 13.12. Netherlands
• 13.13. Qatar
• 13.14. Finland
• 13.15. Sweden
• 13.16. Nigeria
• 13.17. Egypt
• 13.18. Turkey
• 13.19. Israel
• 13.20. Norway
• 13.21. Poland
• 13.22. Switzerland

14. Asia-Pacific Boron Neutron Capture Therapy Market

• 14.1. Introduction
• 14.2. China
• 14.3. India
• 14.4. Japan
• 14.5. Australia
• 14.6. South Korea
• 14.7. Indonesia
• 14.8. Thailand
• 14.9. Philippines
• 14.10. Malaysia
• 14.11. Singapore
• 14.12. Vietnam
• 14.13. Taiwan

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Aviko Radiopharmaceuticals, LLC
  • 15.3.2. BEVATECH GmbH
  • 15.3.3. Cosylab
  • 15.3.4. International Particle Therapy Inc.
  • 15.3.5. Neuboron Medtech Ltd.
  • 15.3.6. Neutron Therapeutics, LLC
  • 15.3.7. RaySearch Laboratories
  • 15.3.8. Stellapharm J.V. Co., Ltd.
  • 15.3.9. Sumitomo Heavy Industries, Ltd.
  • 15.3.10. TAE Life Sciences

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

• FIGURE 1. BORON NEUTRON CAPTURE THERAPY MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 14. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 16. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. BORON NEUTRON CAPTURE THERAPY MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 22. BORON NEUTRON CAPTURE THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 23. BORON NEUTRON CAPTURE THERAPY MARKET: RESEARCHAI
• FIGURE 24. BORON NEUTRON CAPTURE THERAPY MARKET: RESEARCHSTATISTICS
• FIGURE 25. BORON NEUTRON CAPTURE THERAPY MARKET: RESEARCHCONTACTS
• FIGURE 26. BORON NEUTRON CAPTURE THERAPY MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. BORON NEUTRON CAPTURE THERAPY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NUCLEAR REACTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NUCLEAR REACTORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY LINACS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY LINACS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORONATED PORPHYRINS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORONATED PORPHYRINS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORONOPHENYLALANINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORONOPHENYLALANINE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY SODIUM BOROCAPTATE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY SODIUM BOROCAPTATE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY MENINGIOMA, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 53. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 54. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 55. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 56. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 57. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 58. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 59. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 60. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 61. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 62. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 63. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 64. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 65. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. AMERICAS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 67. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 68. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 69. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 70. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 71. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 72. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 73. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 74. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 75. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 76. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 77. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 78. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 79. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 80. UNITED STATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 81. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 82. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 83. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 84. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 85. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 86. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 87. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 88. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 89. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 90. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 91. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 92. CANADA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 93. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 94. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 95. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 96. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 97. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 98. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 99. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 100. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 101. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 102. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 103. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 104. MEXICO BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 105. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 106. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 107. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 108. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 109. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 110. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 111. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 112. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 113. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 114. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 115. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 116. BRAZIL BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 117. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 118. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 119. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 120. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 121. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 122. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 123. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 124. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 125. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 126. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 127. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 128. ARGENTINA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 140. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 141. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. EUROPE, MIDDLE EAST & AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 144. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 146. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 148. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 150. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 152. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 153. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 154. UNITED KINGDOM BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 155. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 156. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 157. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 158. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 159. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 160. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 161. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 162. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 163. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 164. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 165. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 166. GERMANY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 167. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 168. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 169. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 170. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 171. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 172. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 173. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 174. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 175. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 176. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 177. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 178. FRANCE BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 179. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 180. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 181. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 182. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 183. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 184. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 185. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 186. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 187. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 188. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 189. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 190. RUSSIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 191. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 192. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 193. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 194. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 195. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 196. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 197. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 198. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 199. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 200. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 201. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 202. ITALY BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 203. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 204. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 205. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 206. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 207. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 208. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 209. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 210. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 211. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 212. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 213. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 214. SPAIN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 215. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 216. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 217. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 218. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 219. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 220. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 221. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 222. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 227. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 228. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 229. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 230. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 232. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 234. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 236. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 238. SAUDI ARABIA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 240. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 242. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 244. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 246. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 248. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 250. SOUTH AFRICA BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 251. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 252. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 253. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 254. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 255. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 256. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 257. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 258. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 259. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 260. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 261. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 262. DENMARK BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 263. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 264. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 265. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 266. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 267. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 268. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 269. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 270. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 271. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 272. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 273. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 274. NETHERLANDS BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 275. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 276. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 277. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 278. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 279. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 280. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 281. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 282. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 283. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 284. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 285. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 286. QATAR BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 287. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 288. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 289. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 290. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 291. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 292. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 293. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 294. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 295. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
• TABLE 296. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BRAIN TUMORS, 2025-2030 (USD MILLION)
• TABLE 297. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
• TABLE 298. FINLAND BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
• TABLE 299. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2018-2024 (USD MILLION)
• TABLE 300. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY NEUTRON SOURCES, 2025-2030 (USD MILLION)
• TABLE 301. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2018-2024 (USD MILLION)
• TABLE 302. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY PARTICLE ACCELERATORS, 2025-2030 (USD MILLION)
• TABLE 303. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2018-2024 (USD MILLION)
• TABLE 304. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY BORON COMPOUND, 2025-2030 (USD MILLION)
• TABLE 305. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 306. SWEDEN BORON NEUTRON CAPTURE THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 307. SWEDE